Medical technology
Major owner wants to buy ADDvise out of the stock market
Serial acquirer ADDvise Group may be on its way out of the stock market. After a tough autumn marked by reduced sales and...
Medicinteknik
Premium
BrainCool talks emissions and the way forward
Medtech company BrainCool is currently involved in a rights issue...
Emission
Medicinteknik
Video
New US agreement confirms the strength of OssDsign's clinical data
OssDsign continues to advance its positions on the...
Medicinteknik
Premium
Successful PKU study brings Qlife closer to CE marking
Medical technology company Qlife announces that the clinical study for...
Medicinteknik
BrainCool's CEO comments on growth and issuance
With rapidly growing demand, sales uplift in Q3...
Emission
Intervju
Medicinteknik
PHI advances its IVF focus with HoloOocyte
Phase Holographic Imaging pointed out earlier this year...
Intervju
Medicinteknik
Nexstim: from Helsinki to a global brain revolution
Imagine that patients with severe depression could...
Medicinteknik
Is ctDNA the key to the future of cancer care?
In a debate post on LinkedIn, Pontus Rehn argues...
Medicinteknik
How to take medtech to market – tips from those who have succeeded
At the BioStock Life Science Summit, five experienced...
Medicinteknik
Premium
Video
Watch all presentations from this year’s BioStock Summit 2025!
Last week, the BioStock Life Science Summit...
Bioteknik
Medicinteknik
Final adjustments and validation take center stage at Prolight Diagnostics
Prolight Diagnostics continues its preparations for the market launch of...
Intervju
Medicinteknik
BiBBInstruments off the starting blocks for its U.S. launch
BiBBInstruments enters a new phase as...
Intervju
Medicinteknik